Cipla | CIPLA - Betriebsaufwand

Aktienkurs
1,233.80
Täglich Wechseln
4.30 0.35%
Monatlich
0.98%
Jährlich
-19.26%
Q2 Prognose
1,213.25




Betriebsaufwand Veränderung Datum
Arca Biopharma USD 34.43M 326K 2025-12
aTyr Pharma USD 85.61M 58.67M 2025-12
Bio Path USD 488K 4.07M 2025-09
Brainstorm Cell Therapeutics USD 2.24M 197K 2025-12
Capricor Therapeutics USD 29.16M 2.87M 2025-12
Cara Therapeutics USD 5.94M 983K 2025-09
Cipla INR 60.98B 1.06B 2025-12
Dr.Reddys Laboratories INR 73.6B 1.79B 2025-12
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Immunic USD 25.73M 2.91M 2024-09
Infinity Pharmaceuticals USD 10.7M 1.54M 2023-06
Minerva Neurosciences USD 4.52M 155.46K 2024-12
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sun Pharmaceuticals INR 111.11B 6.97B 2025-09
TherapeuticsMD USD 1.41M 50K 2024-06
UPL INR 106.63B 780M 2025-12